Back to search

Article

Weight change and Impact on prognosis in patients with Advanced Non-small Cell Lung Cancer with Concomitant diabetes mellitus treated with SGLT2 inhibitors

2026-01-24

Abstract excerpt

<title>Abstract</title> <p>Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are commonly used to manage diabetes and are known to cause weight loss. This study aimed to clarify whether SGLT2i-induced weight loss influences survival or toxicity during chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and comorbid diabetes. <h4>Methods:</h4> We conducted a retrospective analys...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9291667-80bf-515d-933f-a2358a318509
DOI
10.21203/rs.3.rs-8406171/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Weight change and Impact on prognosis in patients with Advanced Non-small Cell Lung Cancer with Concomitant diabetes mellitus treated with SGLT2 inhibitorsDOI 10.21203/rs.3.rs-8406171/v1
Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation.Semantic proximity
Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial.Semantic proximity
Does metformin improve the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor treatment for patients with advanced non-small-cell lung cancer?Semantic proximity
Prognostic Value of Baseline HbA1c in Advanced Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Retrospective Cohort StudySemantic proximity
Benefits of Metformin Combined with Pemetrexed-Based Platinum Doublets as a First-Line Therapy for Advanced Lung Adenocarcinoma Patients with Diabetes.Semantic proximity
High Body Mass Index Was Related to Favorable Therapeutic Efficacy of Epidermal Growth Factor Receptor Targeted Therapy in Advanced Non-Small Cell Lung CancerSemantic proximity
Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.Semantic proximity
Association of Diabetes Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: a Retrospective Study in JapanSemantic proximity
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsSemantic proximity
Effect of body weight on chronic kidney disease in patients with type II diabetes mellitus without proteinuriaSemantic proximity
Synthetic lethality targeting LKB1 mutant and EGFR wild type human non-small cell lung cancer cells by glucose starvation and SGLT2 inhibitionSemantic proximity
The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer.Semantic proximity
Select a neighboring publication to make it the new centre.